In the last 12 months, insiders at Neuphoria Therapeutics Inc. ($NEUP) filed 12 transactions with the SEC: 1 open-market purchases totaling $3,283,108 and 0 sales totaling $0. Net insider sentiment: net buying.
Neuphoria Therapeutics Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Lynx1 Capital Management LP (TenPercentOwner) — 1 transaction totaling $3,283,108
- Papapetropoulos Spyros (President and CEO) — 3 transactions totaling $19
- Ryan Jane (Director) — 2 transactions totaling $0
- Fisher Alan (Director) — 2 transactions totaling $0
- Davies Peter Miles Winston (Director) — 2 transactions totaling $0
View all SEC Filings for Neuphoria Therapeutics Inc. (NEUP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | Ryan Jane | Director | A | Restricted Stock Units | 8537 | $0.00 | 15,550.0000 | 5,377,329 | 121.73% | 0.16% |
| Jan. 20, 2026 | Fisher Alan | Director | A | Restricted Stock Units | 17073 | $0.00 | 30,731.0000 | 5,377,329 | 125.00% | 0.32% |
| Jan. 20, 2026 | Davies Peter Miles Winston | Director | A | Restricted Stock Units | 8537 | $0.00 | 15,320.0000 | 5,377,329 | 125.86% | 0.16% |
| Jan. 20, 2026 | Wilson David Ian | Director | A | Restricted Stock Units | 8537 | $0.00 | 15,412.0000 | 5,377,329 | 124.17% | 0.16% |
| Oct. 21, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.00001 par value per share | 639110 | $5.14 | 875,328.0000 | 2,357,613 | 270.56% | 27.11% |
| Aug. 27, 2025 | Papapetropoulos Spyros | President and CEO | A | Employee Stock Option (Right-to- Buy) | 34559 | $8.27 | 74,088.0000 | 0 | 87.43% | 0.00% |
| April 16, 2025 | Papapetropoulos Spyros | President and CEO | A | Employee Stock Option (Right-to-Buy) | 27000 | $5.16 | 39,529.0000 | 0 | 215.50% | 0.00% |
| April 16, 2025 | Fisher Alan | Director | A | Restricted Stock Units | 13566 | $0.00 | 13,658.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2025 | Wilson David Ian | Director | A | Restricted Stock Units | 6783 | $0.00 | 6,875.0000 | 0 | 7372.83% | 0.00% |
| April 16, 2025 | Ryan Jane | Director | A | Restricted Stock Units | 6783 | $0.00 | 7,013.0000 | 0 | 2949.13% | 0.00% |
| April 16, 2025 | Davies Peter Miles Winston | Director | A | Restricted Stock Units | 6783 | $0.00 | 6,783.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2025 | Papapetropoulos Spyros | President and CEO | A | Employee Stock Option (Right-to-Buy) | 270000 | $5.16 | 282,529.0000 | 0 | 2155.00% | 0.00% |